Autologous mesenchymal stem cells: clinical applications in amyotrophic lateral sclerosis
Authors:
- Letizia MazziniLMLetizia Mazzini
- Katia MareschiKMKatia Mareschi
- Ivana FerreroIFIvana Ferrero
- Elena VassalloEVElena Vassallo
- Giuseppe OliveriGOGiuseppe Oliveri
- Riccardo BoccalettiRBRiccardo Boccaletti
- Lucia TestaLTLucia Testa
- Sergio LivigniSLSergio Livigni
- Franca FagioliFranca Fagioli
- 19 July 2006
- journal article
- clinical trial
- Published by Taylor & Francis in Neurological Research
- Vol. 28 (5) , 523-526
Abstract
Our study was aimed to evaluate the feasibility and safety of intraspinal cord implantation of autologous mesenchymal stem cells (MSCs) in a few well-monitored amyotrophic lateral sclerosis (ALS) patients. Seven patients affected by definite ALS were enrolled in the study and two patients were treated for compassionate use and monitored for at least 3 years. Bone marrow was collected from the posterior iliac crest according to the standard procedure and MSCs were expanded ex vivo according to Pittenger's protocol. The cells were suspended in 2 ml autologous cerebrospinal fluid and transplanted into the spinal cord by a micrometric pump injector. The in vitro expanded MSCs did not show any bacterial o fungal contamination, hemopoietic cell contamination, chromosomic alterations and early cellular senescence. No patient manifested major adverse events such as respiratory failure or death. Minor adverse events were intercostal pain irradiation and leg sensory dysesthesia, both reversible after a mean period of 6 weeks. No modification of the spinal cord volume or other signs of abnormal cell proliferation were observed. A significant slowing down of the linear decline of the forced vital capacity was evident in four patients 36 months after MSCs transplantation. Our results demonstrate that direct injection of autologous expanded MSCs into the spinal cord of ALS patients is safe, with no significant acute or late toxicity, and well tolerated. The clinical results seem to be encouraging.Keywords
This publication has 17 references indexed in Scilit:
- Motor Neuron Degeneration Promotes Neural Progenitor Cell Proliferation, Migration, and Neurogenesis in the Spinal Cords of Amyotrophic Lateral Sclerosis MiceStem Cells, 2005
- Neurodegeneration Augments the Ability of Bone Marrow-Derived Mesenchymal Stem Cells to Fuse with Purkinje Neurons in Niemann–Pick Type C MiceHuman Gene Therapy, 2005
- Neuro-glial differentiation of human bone marrow stem cells in vitroExperimental Neurology, 2005
- Microglia as potential contributors to motor neuron injury in amyotrophic lateral sclerosisGlia, 2005
- GDNF Delivery Using Human Neural Progenitor Cells in a Rat Model of ALSHuman Gene Therapy, 2005
- Wild-type bone marrow cells ameliorate the phenotype of SOD1-G93A ALS mice and contribute to CNS, heart and skeletal muscle tissuesBrain, 2004
- Rat bone marrow mesenchymal stem cells express glial markers and stimulate nerve regenerationNeuroscience Letters, 2004
- Stem cells for Parkinson disease and ALS: replacement or protection?Nature Medicine, 2004
- Wild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS MiceScience, 2003
- Sciatic nerve regeneration in rats induced by transplantation of in vitro differentiated bone‐marrow stromal cellsEuropean Journal of Neuroscience, 2001